메뉴 건너뛰기




Volumn 80, Issue 4, 2007, Pages 335-340

Rituximab therapy in severe juvenile pemphigus vulgaris

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; RITUXIMAB;

EID: 38849135687     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (25)

References (35)
  • 1
    • 0032881369 scopus 로고    scopus 로고
    • Childhood, neonatal, and stillborn pemphigus vulgaris
    • Bjarnason B, Flosadottir E. Childhood, neonatal, and stillborn pemphigus vulgaris. Int J Dermatol. 1999;38: 680-688.
    • (1999) Int J Dermatol , vol.38 , pp. 680-688
    • Bjarnason, B.1    Flosadottir, E.2
  • 2
    • 0025789652 scopus 로고
    • Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
    • Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991;67:869-877.
    • (1991) Cell , vol.67 , pp. 869-877
    • Amagai, M.1    Klaus-Kovtun, V.2    Stanley, J.R.3
  • 3
    • 0030902370 scopus 로고    scopus 로고
    • Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris
    • Koch PJ, Mahoney MG, Ishikawa H, et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol. 1997;137:1091-1102.
    • (1997) J Cell Biol , vol.137 , pp. 1091-1102
    • Koch, P.J.1    Mahoney, M.G.2    Ishikawa, H.3
  • 4
    • 0028148708 scopus 로고
    • Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells
    • Bachmann MF, Kundig TM, Odermatt B, et al. Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. J Immunol. 1994;153:3386-3397.
    • (1994) J Immunol , vol.153 , pp. 3386-3397
    • Bachmann, M.F.1    Kundig, T.M.2    Odermatt, B.3
  • 5
    • 0036235410 scopus 로고    scopus 로고
    • Plasma cells for a lifetime?
    • Manz RA, Radbruch A. Plasma cells for a lifetime? Eur J Immunol. 2002;32:923-927.
    • (2002) Eur J Immunol , vol.32 , pp. 923-927
    • Manz, R.A.1    Radbruch, A.2
  • 6
    • 16444367429 scopus 로고    scopus 로고
    • Successful rituximab treatment of severe pemphigus vulgaris resistant to multiple immunosuppressants
    • Wenzel J, Bauer R, Bieber T, et al. Successful rituximab treatment of severe pemphigus vulgaris resistant to multiple immunosuppressants. Acta Derm Venereol. 2005;85:185-186.
    • (2005) Acta Derm Venereol , vol.85 , pp. 185-186
    • Wenzel, J.1    Bauer, R.2    Bieber, T.3
  • 7
    • 8744228329 scopus 로고    scopus 로고
    • Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
    • Morrison LH. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab). J Am Acad Dermatol. 2004;51:817-819.
    • (2004) J Am Acad Dermatol , vol.51 , pp. 817-819
    • Morrison, L.H.1
  • 8
    • 2542490336 scopus 로고    scopus 로고
    • Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations
    • Espana A, Fernandez-Galar M, Lloret P, et al. Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations. J Am Acad Dermatol. 2004;50:974-976.
    • (2004) J Am Acad Dermatol , vol.50 , pp. 974-976
    • Espana, A.1    Fernandez-Galar, M.2    Lloret, P.3
  • 9
    • 9144262314 scopus 로고    scopus 로고
    • Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)
    • Dupuy A, Viguier M, Bedane C, et al. Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody). Arch Dermatol. 2004;140: 91-96.
    • (2004) Arch Dermatol , vol.140 , pp. 91-96
    • Dupuy, A.1    Viguier, M.2    Bedane, C.3
  • 10
    • 0041349378 scopus 로고    scopus 로고
    • Anti-CD20 monoclonal anti-body (rituximab) in the treatment of autoimmune diseases, successful result in refractory pemphigus vulgaris: Report of a case
    • Virgolini L, Marzocchi V. Anti-CD20 monoclonal anti-body (rituximab) in the treatment of autoimmune diseases, successful result in refractory pemphigus vulgaris: report of a case. Hoematologica. 2003;88:ELT24.
    • (2003) Hoematologica , vol.88
    • Virgolini, L.1    Marzocchi, V.2
  • 11
    • 0037707715 scopus 로고    scopus 로고
    • Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (rituximab)
    • Cooper HL, Healy E, Theaker JM, et al. Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (rituximab). Clin Exp Dermatol. 2003;28:366-368.
    • (2003) Clin Exp Dermatol , vol.28 , pp. 366-368
    • Cooper, H.L.1    Healy, E.2    Theaker, J.M.3
  • 12
    • 0344406066 scopus 로고    scopus 로고
    • Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
    • Herrmann G, Hunzelmann N, Engert A. Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab). Br J Dermatol. 2003;148:602-603.
    • (2003) Br J Dermatol , vol.148 , pp. 602-603
    • Herrmann, G.1    Hunzelmann, N.2    Engert, A.3
  • 13
    • 0036827616 scopus 로고    scopus 로고
    • Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder
    • Salopek TG, Logsetty S, Tredget EE. Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol. 2002;47:785-788.
    • (2002) J Am Acad Dermatol , vol.47 , pp. 785-788
    • Salopek, T.G.1    Logsetty, S.2    Tredget, E.E.3
  • 14
    • 0028108050 scopus 로고
    • CD20: A regulator of cell-cycle progression of B lymphocytes
    • Tedder TF, Engel P. CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today. 1994;15: 450-454.
    • (1994) Immunol Today , vol.15 , pp. 450-454
    • Tedder, T.F.1    Engel, P.2
  • 15
    • 0035205004 scopus 로고    scopus 로고
    • Pathophysiology and therapy of pemphigus in the 21st century
    • Stanley JR. Pathophysiology and therapy of pemphigus in the 21st century. J Dermatol. 2001;28:645-646.
    • (2001) J Dermatol , vol.28 , pp. 645-646
    • Stanley, J.R.1
  • 16
    • 0033911628 scopus 로고    scopus 로고
    • Patterns of remission in pemphigus vulgaris
    • Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol. 2000;42:422-427.
    • (2000) J Am Acad Dermatol , vol.42 , pp. 422-427
    • Herbst, A.1    Bystryn, J.C.2
  • 17
    • 0345724922 scopus 로고    scopus 로고
    • Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris
    • Mimouni D, Nousari CH, Cummins DL, et al. Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris. J Am Acad Dermatol. 2003;49:1059-1062.
    • (2003) J Am Acad Dermatol , vol.49 , pp. 1059-1062
    • Mimouni, D.1    Nousari, C.H.2    Cummins, D.L.3
  • 18
    • 0023723595 scopus 로고
    • Plasmapheresis therapy of pemphigus
    • Bystryn JC. Plasmapheresis therapy of pemphigus. Arch Dermatol. 1988;124:1702-1704.
    • (1988) Arch Dermatol , vol.124 , pp. 1702-1704
    • Bystryn, J.C.1
  • 19
    • 0023148121 scopus 로고
    • Azathioprine in the treatment of pemphigus vulgaris. a long-term follow-up
    • Aberer W, Wolff-Schreiner EC, Stingl G, et al. Azathioprine in the treatment of pemphigus vulgaris. a long-term follow-up. J Am Acad Dermatol. 1987;16(3 pt 1): 527-533.
    • (1987) J Am Acad Dermatol , vol.16 , Issue.3 PART 1 , pp. 527-533
    • Aberer, W.1    Wolff-Schreiner, E.C.2    Stingl, G.3
  • 20
    • 85047692468 scopus 로고
    • Pemphigus vulgaris. combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine
    • Fine JD, Appell ML, Green LK, et al. Pemphigus vulgaris. combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine. Arch Dermatol. 1988;124:236-239.
    • (1988) Arch Dermatol , vol.124 , pp. 236-239
    • Fine, J.D.1    Appell, M.L.2    Green, L.K.3
  • 21
    • 0023413360 scopus 로고
    • Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris
    • Euler HH, Loffler H, Christophers E. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Oermatol. 1987;123: 1205-1210.
    • (1987) Arch Oermatol , vol.123 , pp. 1205-1210
    • Euler, H.H.1    Loffler, H.2    Christophers, E.3
  • 22
    • 0035977173 scopus 로고    scopus 로고
    • Rituximab: Mechanisms and applications
    • Johnson PW, Glennie MJ. Rituximab: mechanisms and applications. Br J Cancer. 2001;85:1619-1623.
    • (2001) Br J Cancer , vol.85 , pp. 1619-1623
    • Johnson, P.W.1    Glennie, M.J.2
  • 23
    • 0036822286 scopus 로고    scopus 로고
    • An open study of B lymphocyte depletion in systemic lupus erythematosus
    • Leandro MJ, Edwards JC, Cambridge G, et al. An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum. 2002;46: 2673-2677.
    • (2002) Arthritis Rheum , vol.46 , pp. 2673-2677
    • Leandro, M.J.1    Edwards, J.C.2    Cambridge, G.3
  • 24
    • 0344824642 scopus 로고    scopus 로고
    • Novel therapies in pediatric rheumatic disease
    • Chira P, Sandborg CI. Novel therapies in pediatric rheumatic disease. Curr Opin Pediatr. 2003;15: 579-585.
    • (2003) Curr Opin Pediatr , vol.15 , pp. 579-585
    • Chira, P.1    Sandborg, C.I.2
  • 25
    • 0014986054 scopus 로고
    • Correlation of pemphigoid and pemphigus antibody titers with activity of disease
    • Sams WM Jr, Jordon RE. Correlation of pemphigoid and pemphigus antibody titers with activity of disease. Br J Dermatol 1971;84:7-13.
    • (1971) Br J Dermatol , vol.84 , pp. 7-13
    • Sams Jr, W.M.1    Jordon, R.E.2
  • 26
    • 0037318312 scopus 로고    scopus 로고
    • Entero-viral meningoencephalitis after anti-CD20 (rituximab) treatment
    • Epub January 16
    • Quartier P, Toumilhac O, Archimbaud C, et al. Entero-viral meningoencephalitis after anti-CD20 (rituximab) treatment. Clin Infect Dis. 2003;36:e47-e49. Epub January 16, 2003.
    • (2003) Clin Infect Dis. 2003 , vol.36
    • Quartier, P.1    Toumilhac, O.2    Archimbaud, C.3
  • 27
    • 0037926853 scopus 로고    scopus 로고
    • Rituximab for the treatment of refractory autoimmune hemolytic anemia in children
    • Epub January 16
    • Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood. 2003;101:3857-3861. Epub January 16, 2003.
    • (2003) Blood. 2003 , vol.101 , pp. 3857-3861
    • Zecca, M.1    Nobili, B.2    Ramenghi, U.3
  • 28
    • 38849196629 scopus 로고    scopus 로고
    • Rituxan [package insert, South San Francisco, Calif: Genentech, Inc; 2007
    • Rituxan [package insert]. South San Francisco, Calif: Genentech, Inc; 2007.
  • 29
    • 0038309769 scopus 로고    scopus 로고
    • Neutropenia in patients treated with rituximab
    • Voog E, Morschhauser F, Solal-Celigny P. Neutropenia in patients treated with rituximab. N Engl J Med. 2003;348:2691-2694.
    • (2003) N Engl J Med , vol.348 , pp. 2691-2694
    • Voog, E.1    Morschhauser, F.2    Solal-Celigny, P.3
  • 30
    • 0141813574 scopus 로고    scopus 로고
    • Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2
    • Golay J, Manganini M, Facchinetti V, et al. Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2. Haematologica. 2003;88:1002-1012.
    • (2003) Haematologica , vol.88 , pp. 1002-1012
    • Golay, J.1    Manganini, M.2    Facchinetti, V.3
  • 31
    • 0042346042 scopus 로고    scopus 로고
    • Complement activation determines the therapeutic activity of rituximab in vivo
    • Di Gaetano N, Cittera E, Nota R, et al. Complement activation determines the therapeutic activity of rituximab in vivo. J Immunol. 2003;171:1581-1587.
    • (2003) J Immunol , vol.171 , pp. 1581-1587
    • Di Gaetano, N.1    Cittera, E.2    Nota, R.3
  • 32
    • 0029016147 scopus 로고
    • Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balb/c 3T3 cells
    • Kanzaki M, Shibata H, Mogami H, et al. Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balb/c 3T3 cells. J Biol Chem. 1995;270:13099-13104.
    • (1995) J Biol Chem , vol.270 , pp. 13099-13104
    • Kanzaki, M.1    Shibata, H.2    Mogami, H.3
  • 33
    • 0022202908 scopus 로고
    • The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle
    • Golay JT, Clark EA, Beverley PC. The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle. J Immunol. 1985;135: 3795-3801.
    • (1985) J Immunol , vol.135 , pp. 3795-3801
    • Golay, J.T.1    Clark, E.A.2    Beverley, P.C.3
  • 34
    • 0033067232 scopus 로고    scopus 로고
    • Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: Results of a phase II trial of rituximab
    • Davis TA, White CA, Grillo-Lopez AJ, et al. Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab. J Clin Oncol. 1999;17:1851-1857.
    • (1999) J Clin Oncol , vol.17 , pp. 1851-1857
    • Davis, T.A.1    White, C.A.2    Grillo-Lopez, A.J.3
  • 35
    • 33644830710 scopus 로고    scopus 로고
    • Successful treatment of refractory childhood pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
    • Kong HH, Prose NS, Ware RE, et al. Successful treatment of refractory childhood pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab). Pediatr Dermatol. 2005;22:461-464.
    • (2005) Pediatr Dermatol , vol.22 , pp. 461-464
    • Kong, H.H.1    Prose, N.S.2    Ware, R.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.